Baseline characteristics

Combination Chemotherapy and Rituximab in Treating Patients With HIV-Associated Stage I, Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma · Source last updated 2014-05-14

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

1. counts

   1. group Id

      BG000

      value

      51

   2. group Id

      BG001

      value

      55

   3. group Id

      BG002

      value

      106

   units

   Participants

groups

1. description

   Patients receive rituximab IV over 2-4 hours prior to each course of chemotherapy. Treatment repeats every 3 weeks for 4-6 courses. Patients who achieve a complete response after 4 courses of chemotherapy and rituximab receive additional rituximab alone weekly for 2 weeks.

   id

   BG000

   title

   EPOCH + Concurrent Rituximab

2. description

   Patients do not receive rituximab concurrently with chemotherapy. Beginning 4 weeks after completion of chemotherapy, patients receive rituximab IV over 2-4 hours weekly for 6 weeks.

   id

   BG001

   title

   EPOCH Followed by Rituximab

3. description

   Total of all reporting groups

   id

   BG002

   title

   Total

measures

1. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            0

         2. group Id

            BG001

            value

            0

         3. group Id

            BG002

            value

            0

         title

         <=18 years

      2. measurements

         1. group Id

            BG000

            value

            51

         2. group Id

            BG001

            value

            54

         3. group Id

            BG002

            value

            105

         title

         Between 18 and 65 years

      3. measurements

         1. group Id

            BG000

            value

            0

         2. group Id

            BG001

            value

            1

         3. group Id

            BG002

            value

            1

         title

         >=65 years

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Age, Categorical

   unit Of Measure

   Participants

2. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            spread

            8.4

            value

            42.6

         2. group Id

            BG001

            spread

            9.4

            value

            42.6

         3. group Id

            BG002

            spread

            8.9

            value

            42.6

   dispersion Type

   STANDARD_DEVIATION

   param Type

   MEAN

   title

   Age, Continuous

   unit Of Measure

   years

3. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            8

         2. group Id

            BG001

            value

            7

         3. group Id

            BG002

            value

            15

         title

         Female

      2. measurements

         1. group Id

            BG000

            value

            43

         2. group Id

            BG001

            value

            48

         3. group Id

            BG002

            value

            91

         title

         Male

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Sex: Female, Male

   unit Of Measure

   Participants

4. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            51

         2. group Id

            BG001

            value

            55

         3. group Id

            BG002

            value

            106

      title

      United States

   param Type

   NUMBER

   title

   Region of Enrollment

   unit Of Measure

   participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice